Bioceptive

Executive Summary

Bioceptive is a privately held women's health medical device company headquartered in New Orleans, LA. Founded in 1966, the company specializes in single-use, disposable devices that reduce pain and improve outcomes for gynecological procedures. Its core products include the FDA-approved Cervical Suction Retractor and a proprietary IUD Inserter system. The Cervical Suction Retractor is designed to facilitate smoother and less painful IUD insertions by stabilizing the cervix and reducing procedural discomfort. The IUD Inserter system aims to simplify insertion and improve placement accuracy. With FDA approval already secured, Bioceptive is poised to capture significant market share in the large and growing women's health device segment. However, as a private company with no disclosed revenue or funding details, commercial traction remains unverified. The company's long history suggests operational experience, but the lack of public partnerships or sales data limits visibility. Overall, Bioceptive's regulatory milestone and innovative product portfolio position it well, but execution risks and competitive pressures remain.

Upcoming Catalysts (preview)

• Q3 2026Commercial launch of proprietary IUD Inserter system70% success
• TBDStrategic partnership or distribution agreement with a major women's health company50% success
• TBDAdditional FDA clearance for next-generation device or expanded indication60% success